PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
10.39%
Revenue growth of 10.39% vs. zero growth in Healthcare. Walter Schloss might still want to see if it can translate into profits.
9.46%
Gross profit growth of 9.46% while Healthcare median is zero. Walter Schloss might see a slight advantage that could be built upon.
9.87%
EBIT growth of 9.87% while Healthcare median is zero. Walter Schloss would see a marginal edge that could be expanded upon.
9.85%
Operating income growth of 9.85% while Healthcare median is zero. Walter Schloss might see a modest advantage that can expand.
20.61%
Net income growth of 20.61% while Healthcare median is zero. Walter Schloss might see potential if moderate gains can keep rising.
20.62%
EPS growth of 20.62% while Healthcare median is zero. Walter Schloss might see a slight edge that could compound over time.
20.62%
Diluted EPS growth of 20.62% while Healthcare median is zero. Walter Schloss might see a slight edge that could improve over time.
-0.00%
Share reduction while Healthcare median is 0.00%. Seth Klarman would see a relative advantage if others are diluting.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
57.10%
10Y CAGR of 57.10% while Healthcare median is zero. Walter Schloss might see a slight advantage that can compound over very long horizons.
57.10%
5Y CAGR of 57.10% while Healthcare is zero. Walter Schloss might see a slight improvement that could compound if momentum builds.
57.10%
3Y CAGR of 57.10% while Healthcare median is zero. Walter Schloss might see a modest improvement overshadowing the broader sector’s stagnation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
75.35%
Net income/share CAGR exceeding 1.5x Healthcare median of 14.05% over a decade. Joel Greenblatt might see a standout compounder of earnings.
75.35%
5Y net income/share CAGR > 1.5x Healthcare median of 7.45%. Joel Greenblatt might see superior mid-term capital allocation or product strength.
75.35%
3Y net income/share CAGR > 1.5x Healthcare median of 8.99%. Joel Greenblatt might see a recent surge from market share gains or cost synergy.
81.97%
Equity/share CAGR of 81.97% while Healthcare median is zero. Walter Schloss might see a modest advantage in net worth accumulation that could matter long term.
81.97%
5Y equity/share CAGR of 81.97% while Healthcare median is zero. Walter Schloss sees a slight positive that might compound if management executes well.
81.97%
3Y equity/share CAGR of 81.97% while Healthcare median is zero. Walter Schloss sees a modest short-term advantage that could compound if momentum persists.
-26.67%
Dividend declines over 10 years while Healthcare median is 0.00%. Seth Klarman would see a relative disadvantage if peers consistently raised payouts.
-26.67%
Dividend cuts or stagnation while Healthcare median is 0.00%. Seth Klarman sees a disadvantage in shareholder returns vs. peers.
-26.67%
Dividend reductions while Healthcare median grows. Seth Klarman sees a near-term disadvantage if peers maintain or raise payouts.
No Data
No Data available this quarter, please select a different quarter.
4.39%
Inventory growth of 4.39% while Healthcare median is zero. Walter Schloss checks if we’re preparing for a sales push or risking overstock.
13.38%
Asset growth of 13.38% while Healthcare median is zero. Walter Schloss sees a slight advantage if expansions yield good returns on capital.
5.97%
BV/share growth of 5.97% while Healthcare is zero. Walter Schloss sees a slight lead that can expand if sustained over time.
51.23%
Debt growth of 51.23% while Healthcare median is zero. Walter Schloss might see a modest difference that matters if interest coverage is tight.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.